middle.news
Cogstate Advances with 12% Revenue Growth and Expanding Clinical Trial Contracts
8:26am on Thursday 19th of February, 2026 AEDT
•
Healthcare
Read Story
Cogstate Advances with 12% Revenue Growth and Expanding Clinical Trial Contracts
8:26am on Thursday 19th of February, 2026 AEDT
Key Points
12% revenue growth to $26.9 million in H1 2026
13% increase in Clinical Trials revenue to $25.7 million
Net profit before tax up 2% to $5.34 million
Contracted future Clinical Trials revenue rises 10% to $92.3 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
COGSTATE (ASX:CGS)
OPEN ARTICLE